VedaBio Analysis
What is VedaBio?
VedaBio is a biotechnology company specializing in ultra-rapid molecular detection using its CRISPR Cascade™ platform for accurate results without target amplification.
Product Features & Capabilities
- Ultra-rapid molecular detection, CRISPR Cascade™ platform, target amplification-free detection, massive multiplexing capability, rapid reprogramming for new targets.
Who are the founders of VedaBio
AG
Anurup Ganguli
Founder
Investors
- OMX Ventures (lead investor)
- Other undisclosed investors contributing to the initial funding of over $40 million
Market Focus
VedaBio primarily focuses on the biotechnology industry, specifically in the area of molecular detection using its CRISPR Cascade™ platform for accurate detection of multiple analytes.
Business Model
Funding through investments; revenue from molecular detection services and technology licensing.
Competitors Overview
VedaBio operates in the biotechnology sector, focusing on ultra-rapid molecular detection through its CRISPR Cascade™ platform. Its main competitors include:
- Sherlock Biosciences: This company utilizes CRISPR technology to develop rapid and accurate diagnostic tests for various applications,
See something that needs updating? Suggest edits to this profile.